Incyte
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
SCHRECK PATRICIA A officer: EVP, General Counsel
Common Stock 50,000 $6.15 $307,500
Sale
SCHRECK PATRICIA A officer: EVP, General Counsel
Common Stock 50,000 $20.67 $1,033,500
Option
SCHRECK PATRICIA A officer: EVP, General Counsel
Non-Qualified Stock Options 50,000 $6.15 $307,500
Sale
SCHRECK PATRICIA A officer: EVP, General Counsel
Common Stock 50,000 $6.15 $307,500
Option
SCHRECK PATRICIA A officer: EVP, General Counsel
Common Stock 50,000 $6.15 $307,500
Sale
WHITFIELD ROY A director
Common Stock 10,000 $19.78 $197,800
Option
SCHRECK PATRICIA A officer: EVP, General Counsel
Incentive Stock Options 50,000 $6.15 $307,500
Sale
CHARDONNET LAURENT other: Vice President and Treas..
Common Stock 5,343 $19.55 $104,456
Sale
WHITFIELD ROY A director
Common Stock 10,000 $19.31 $193,140
Option
METCALF BRIAN W officer: Chief Drug Discovery S..
Common Stock 100,000 $5.46 $546,000
Sale
METCALF BRIAN W officer: Chief Drug Discovery S..
Common Stock 100,000 $17.42 $1,742,000
Option
METCALF BRIAN W officer: Chief Drug Discovery S..
Non Qualified Stock Option (right to buy) 82,688 $5.46 $451,476
Option
CHARDONNET LAURENT other: Vice President and Treas..
Incentive Stock Option (right to buy) 3,335 $3.11 $10,372
Sale
CHARDONNET LAURENT other: Vice President and Treas..
Common Stock 25,000 $17.04 $425,925
Option
CHARDONNET LAURENT other: Vice President and Treas..
Common Stock 25,000 $3.11 $77,750
Option
CHARDONNET LAURENT other: Vice President and Treas..
Non Qualified Stock Option (right to buy) 21,665 $3.11 $67,378
Option
SCHRECK PATRICIA A officer: EVP, General Counsel
Non Qualified Stock Option (right to buy) 100,000 $4.29 $428,500
Option
SCHRECK PATRICIA A officer: EVP, General Counsel
Common Stock 100,000 $4.29 $428,500
Sale
SCHRECK PATRICIA A officer: EVP, General Counsel
Common Stock 100,000 $16.5 $1,650,000
Sale
WHITFIELD ROY A director
Common Stock 10,000 $16.03 $160,260
Option
ARIKO BARRY A director
Non Qualified Stock Option (right to buy) 834 $14.13 $11,784
Option
ARIKO BARRY A director
Common Stock 20,834 $14.13 $294,384
Sale
WHITFIELD ROY A director
Common Stock 10,000 $14.71 $147,050
Option
METCALF BRIAN W officer: Chief Drug Discovery S..
Common Stock 160,000 $10.59 $1,693,600
Sale
METCALF BRIAN W officer: Chief Drug Discovery S..
Common Stock 159,800 $14.27 $2,279,867
Option
METCALF BRIAN W officer: Chief Drug Discovery S..
Non-Qualified Stock Options 50,000 $14.25 $712,500
Sale
METCALF BRIAN W officer: Chief Drug Discovery S..
Common Stock 50,000 $14.25 $712,500
Option
METCALF BRIAN W officer: Chief Drug Discovery S..
Common Stock 50,000 $5.97 $298,500
Option
METCALF BRIAN W officer: Chief Drug Discovery S..
Non-Qualified Stock Options 47,223 $5.97 $281,921
Purchase
DE SCHUTTER RICHARD U director, other: Chairman
4.75% Convertible Senior Notes due 2015 150,000 $8.78 $1,317,000
Option
FRIEDMAN PAUL A director
Common Stock 20,000 $8.64 $172,800
Option
FRIEDMAN PAUL A director
Incentive Stock Option (right to buy) 20,000 $8.64 $172,800
Option
METCALF BRIAN W officer: Chief Drug Discovery S..
Common Stock 50,000 $5.97 $298,500
Option
METCALF BRIAN W officer: Chief Drug Discovery S..
Non-Qualified Stock Options 50,000 $5.97 $298,500
Sale
METCALF BRIAN W officer: Chief Drug Discovery S..
Common Stock 50,000 $5.97 $298,500
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
3.5% Senior Convertible Note due 2011 7,598,000 $11.22 $85,249,560
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 4,534,000 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 124,000 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
3.5% Senior Convertible Note due 2011 206,000 $11.22 $2,311,320
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
Common Stock 40,310 $6.19 $249,519
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
Incentive Stock Options 15,000 $4.19 $62,850
Sale
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
Common Stock 40,310 $15.83 $638,228
Sale
WHITFIELD ROY A director
Common Stock 10,000 $17.14 $171,370
Sale
WHITFIELD ROY A director
Common Stock 10,000 $17 $170,000
Sale
WHITFIELD ROY A director
Common Stock 1,000 $15.9 $15,900
Sale
WHITFIELD ROY A director
Common Stock 10,000 $16.01 $160,100
Sale
WHITFIELD ROY A director
Common Stock 29,523 $16.99 $501,537
Sale
WHITFIELD ROY A director
Common Stock 4,730 $16.95 $80,174
Sale
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
Common Stock 70,150 $14.86 $1,042,499
Sale
14159 CAPITAL (GP), LLC director, 10 percent owner
Common Stock 5,681 $14.86 $84,425

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.